Cargando…

A data-driven approach links microglia to pathology and prognosis in amyotrophic lateral sclerosis

Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease that lacks a predictive and broadly applicable biomarker. Continued focus on mutation-specific upstream mechanisms has yet to predict disease progression in the clinic. Utilising cellular pathology common to the majority...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cooper-Knock, Johnathan, Green, Claire, Altschuler, Gabriel, Wei, Wenbin, Bury, Joanna J., Heath, Paul R., Wyles, Matthew, Gelsthorpe, Catherine, Highley, J. Robin, Lorente-Pons, Alejandro, Beck, Tim, Doyle, Kathryn, Otero, Karel, Traynor, Bryan, Kirby, Janine, Shaw, Pamela J., Hide, Winston
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5353945/ https://www.ncbi.nlm.nih.gov/pubmed/28302159 http://dx.doi.org/10.1186/s40478-017-0424-x

Ejemplares similares

C9ORF72 GGGGCC Expanded Repeats Produce Splicing Dysregulation which Correlates with Disease Severity in Amyotrophic Lateral Sclerosis
por: Cooper-Knock, Johnathan, et al.
Publicado: (2015)

Comparison of Blood RNA Extraction Methods Used for Gene Expression Profiling in Amyotrophic Lateral Sclerosis
por: Bayatti, Nadhim, et al.
Publicado: (2014)

The Spectrum of C9orf72-mediated Neurodegeneration and Amyotrophic Lateral Sclerosis
por: Cooper-Knock, Johnathan, et al.
Publicado: (2015)

Multifaceted Genes in Amyotrophic Lateral Sclerosis-Frontotemporal Dementia
por: Ranganathan, Ramya, et al.
Publicado: (2020)

Targeted Genetic Screen in Amyotrophic Lateral Sclerosis Reveals Novel Genetic Variants with Synergistic Effect on Clinical Phenotype
por: Cooper-Knock, Johnathan, et al.
Publicado: (2017)

Gamma-synuclein pathology in amyotrophic lateral sclerosis
por: Peters, Owen M, et al.
Publicado: (2015)

A Y374X TDP43 truncation leads to an altered metabolic profile in amyotrophic lateral sclerosis fibroblasts driven by pyruvate and TCA cycle intermediate alterations
por: Allen, Scott P., et al.
Publicado: (2023)

The widening spectrum of C9ORF72-related disease; genotype/phenotype correlations and potential modifiers of clinical phenotype
por: Cooper-Knock, Johnathan, et al.
Publicado: (2014)

Small RNA Sequencing of Sporadic Amyotrophic Lateral Sclerosis Cerebrospinal Fluid Reveals Differentially Expressed miRNAs Related to Neural and Glial Activity
por: Waller, Rachel, et al.
Publicado: (2018)

Physical activity as an exogenous risk factor for amyotrophic lateral sclerosis: a review of the evidence
por: Chapman, Laura, et al.
Publicado: (2023)

Value of systematic genetic screening of patients with amyotrophic lateral sclerosis
por: Shepheard, Stephanie R, et al.
Publicado: (2021)

Antisense RNA foci in the motor neurons of C9ORF72-ALS patients are associated with TDP-43 proteinopathy
por: Cooper-Knock, Johnathan, et al.
Publicado: (2015)

Investigating cell death mechanisms in amyotrophic lateral sclerosis using transcriptomics
por: Heath, Paul R., et al.
Publicado: (2013)

The genetics of amyotrophic lateral sclerosis: current insights
por: Alsultan, Afnan A, et al.
Publicado: (2016)

Mutations in the Glycosyltransferase Domain of GLT8D1 Are Associated with Familial Amyotrophic Lateral Sclerosis
por: Cooper-Knock, Johnathan, et al.
Publicado: (2019)

Sequestration of multiple RNA recognition motif-containing proteins by C9orf72 repeat expansions
por: Cooper-Knock, Johnathan, et al.
Publicado: (2014)

Serum miRNAs miR-206, 143-3p and 374b-5p as potential biomarkers for amyotrophic lateral sclerosis (ALS)
por: Waller, Rachel, et al.
Publicado: (2017)

Case report of concurrent Fabry disease and amyotrophic lateral sclerosis supports a common pathway of pathogenesis
por: Beer, Alexander M., et al.
Publicado: (2016)

C9ORF72 hexanucleotide repeat exerts toxicity in a stable, inducible motor neuronal cell model, which is rescued by partial depletion of Pten
por: Stopford, Matthew J., et al.
Publicado: (2017)

The gut microbiome: a key player in the complexity of amyotrophic lateral sclerosis (ALS)
por: Boddy, Sarah L., et al.
Publicado: (2021)

The Pathway Coexpression Network: Revealing pathway relationships
por: Pita-Juárez, Yered, et al.
Publicado: (2018)

Proteinopathies as Hallmarks of Impaired Gene Expression, Proteostasis and Mitochondrial Function in Amyotrophic Lateral Sclerosis
por: Benson, Bridget C., et al.
Publicado: (2021)

Lack of unique neuropathology in amyotrophic lateral sclerosis associated with p.K54E angiogenin (ANG) mutation
por: Kirby, J, et al.
Publicado: (2013)

Expanding the genetics of amyotrophic lateral sclerosis and frontotemporal dementia
por: Schymick, Jennifer C, et al.
Publicado: (2012)

Simultaneous and independent detection of C9ORF72 alleles with low and high number of GGGGCC repeats using an optimised protocol of Southern blot hybridisation
por: Buchman, Vladimir L, et al.
Publicado: (2013)

Atypical TDP‐43 protein expression in an ALS pedigree carrying a p.Y374X truncation mutation in TARDBP
por: Cooper‐Knock, Johnathan, et al.
Publicado: (2022)

Exploring the Disease-Associated Microglia State in Amyotrophic Lateral Sclerosis
por: Jauregui, Carlota, et al.
Publicado: (2023)

The established and emerging roles of astrocytes and microglia in amyotrophic lateral sclerosis and frontotemporal dementia
por: Radford, Rowan A., et al.
Publicado: (2015)

The Overlapping Genetics of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
por: Abramzon, Yevgeniya A., et al.
Publicado: (2020)

Lysosomal and phagocytic activity is increased in astrocytes during disease progression in the SOD1 (G93A) mouse model of amyotrophic lateral sclerosis
por: Baker, David J., et al.
Publicado: (2015)

Physical exercise is a risk factor for amyotrophic lateral sclerosis: Convergent evidence from Mendelian randomisation, transcriptomics and risk genotypes
por: Julian, Thomas H, et al.
Publicado: (2021)

The microbiota restrains neurodegenerative microglia in a model of amyotrophic lateral sclerosis
por: Cox, Laura M., et al.
Publicado: (2022)

Disrupted glycosylation of lipids and proteins is a cause of neurodegeneration
por: Moll, Tobias, et al.
Publicado: (2020)

The relative resistance of children to sepsis mortality: from pathways to drug candidates
por: Joachim, Rose B, et al.
Publicado: (2018)

Projected increase in amyotrophic lateral sclerosis from 2015 to 2040
por: Arthur, Karissa C., et al.
Publicado: (2016)

TDP-43 Is Not a Common Cause of Sporadic Amyotrophic Lateral Sclerosis
por: Guerreiro, Rita J., et al.
Publicado: (2008)

S[+] Apomorphine is a CNS penetrating activator of the Nrf2-ARE pathway with activity in mouse and patient fibroblast models of amyotrophic lateral sclerosis()
por: Mead, Richard J., et al.
Publicado: (2013)

Unbiased metabolome screen leads to personalized medicine strategy for amyotrophic lateral sclerosis
por: Boddy, Sarah, et al.
Publicado: (2022)

Dysregulated microRNAs in amyotrophic lateral sclerosis microglia modulate genes linked to neuroinflammation
por: Parisi, C, et al.
Publicado: (2013)

Little Helpers or Mean Rogue—Role of Microglia in Animal Models of Amyotrophic Lateral Sclerosis
por: Cihankaya, Hilal, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ghgm0u4qh6b617e7u26l25ss52